Type I interferon signaling in systemic immune cells from patients with alcoholic cirrhosis and its association with outcome - CRI

Rechercher Intranet

Auteurs

Weiss Emmanuel,

Rautou Pierre-Emmanuel,

Fasseu M,

Giabicani M,

De Chambrun M,

Minsart C,

Gustot Thierry,

Couvineau Alain,

Maiwall,

Hurtado-Nedelec Maria Margarita,

Pilard N,

Lebrec D,

Valla Dominique,

Durand François,

De La Grange P,

Monteiro Renato,

Paugam-Burtz Catherine,

Lotersztajn Sophie,

Moreau Richard,

Autres publications

Genetic predisposition to porto-sinusoidal vascular disorder

Hepatology.

01 Fév 2026

Auteurs :

Ciriaci Nadia,

Bertin Lise,

Rautou Pierre-Emmanuel,

Elexacaftor-tezacaftor-ivacaftor and cystic fibrosis liver disease: A turning point that calls for cautious optimism

JHEP Rep

26 Nov 2025

Auteurs :

Rautou Pierre-Emmanuel,

Sophie Hillaire,

Simone Gambazza,

Carla Colombo,

EASL Clinical Practice Guidelines on vascular diseases of the liver

J Hepatol.

12 Nov 2025

Auteurs :

Rautou Pierre-Emmanuel,

Moga Lucile,

Virginia Hernandez-Gea,

Walter Ageno,

Sarwa Darwish Murad,

Juan-Carlos Garcia-Pagan,

Maria Guido,

Valérie McLin,

Dhiraj Tripathi,

Vilgrain Valérie,

European Association for the Study of the Liver,

Liver biopsy quality criteria to exclude cirrhosis in case of suspicion of porto-sinusoidal vascular disorder

JHEP Reports

09 Nov 2025

Auteurs :

Chloé de Broucker,

Paradis Valérie,

Maria Luisa Botero,

Albuquerque Miguel,

Payancé Audrey,

Plessier Aurélie,

Elkrief Laure,

Durand François,

Sophie Hillaire,

Paul-Emile Zafar,

Juan Carlos Garcia Pagan,

Rautou Pierre-Emmanuel,